Enzo Biochem, Inc., entered into an agreement for Labcorp to acquire the assets of Enzo’s Clinical Laboratory division (Enzo Clinical Labs). The transaction between follows several steps initiated by Enzo in 2022 to advance the company’s “focused return” initiative to maximize shareholder value. “Completion of the sale will position Enzo to assess and execute on further actions to increase shareholder value and advance our global leadership within the life sciences sector,” said Hamid Erfa...